Stocks
Cortexyme () Operating Income US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -10.4 | -12.1 | -39.2 | -78.9 | -89.9 | -149.4 | |||
| Changes by years, y/y, % | +17% | +223% | +101% | +14% | +71.6% | ||||
Cortexyme. Operating Income, bln rub
Cortexyme. Operating Income, changes, %
Cortexyme. Operating Income, sum by quarters, bln rub
Cortexyme () Operating Income US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| Operating Income, bln rub | -21.8 | -21.7 | -89.9 | -21.6 | -16.3 | -149.4 | ||
| Changes by years, y/y, % | +19% | -1% | +331% | -7% | -25% | |||
| Changes by quarters, q/q, % | -7% | 0% | +315% | -76% | -25% | |||
